Corneal endothelial cells provide evidence of accelerated cellular senescence associated with HIV infection: a case-control study by Pathai, Sophia et al.
Corneal Endothelial Cells Provide Evidence of
Accelerated Cellular Senescence Associated with HIV
Infection: A Case-Control Study
Sophia Pathai1,2*, Stephen D. Lawn2,3, Paul G. Shiels4, Helen A. Weiss5, Colin Cook6, Robin Wood2,
Clare E. Gilbert1
1 International Centre for Eye Health, Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London,
United Kingdom, 2Desmond Tutu HIV Centre, Institute of Infectious Diseases and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, Cape Town,
South Africa, 3Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene & Tropical Medicine, London, United Kingdom,
4 Institute of Cancer Sciences, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom, 5Medical Research Council Tropical
Epidemiology Group, Faculty of Epidemiology and Population Health, London School of Hygiene & Tropical Medicine, London, United Kingdom, 6Department of
Ophthalmology, Faculty of Health Sciences, University of Cape Town, H53 Old Main Building, Groote Schuur Hospital, Cape Town, South Africa
Abstract
Background: Cellular senescence may be a key factor in HIV-related premature biological aging. We assessed features of the
corneal endothelium that are known to be associated with biological aging, and cellular senescence markers in HIV-infected
adults.
Methods: Case-control study of 242 HIV-infected adults and 249 matched controls. Using specular microscopy, the corneal
endothelium was assessed for features of aging (low endothelial cell density [ECD], high variation in cell size, and low
hexagonality index). Data were analysed by multivariable regression. CDKN2A expression (a cell senescence mediator) was
measured in peripheral blood leukocytes and 8-hydroxy-29-deoxyguanosine (8-OHDG; an oxidative DNA damage marker)
levels were measured in plasma.
Results: The median age of both groups was 40 years. Among HIV-infected adults, 88% were receiving antiretroviral therapy
(ART); their median CD4 count was 468 cells/mL. HIV infection was associated with increased odds of variation in cell size
(OR = 1.67; 95% CI: 1.00–2.78, p = 0.04). Among HIV-infected participants, low ECD was independently associated with
current CD4 count ,200 cells/mL (OR = 2.77; 95%CI: 1.12–6.81, p = 0.03). In participants on ART with undetectable viral load,
CDKN2A expression and 8-OHDG levels were higher in those with accelerated aging, as reflected by lower ECD.
Conclusions: The corneal endothelium shows features consistent with HIV-related accelerated senescence, especially
among those with poor immune recovery.
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Introduction
Patients receiving antiretroviral therapy (ART) are at increased
risk of age-related non-AIDS morbidity and mortality compared
with HIV-seronegative persons [1,2]. It is speculated that as those
with HIV age chronologically, they are also likely to undergo
accelerated biological aging, mediated by increased cellular
senescence. This may be due to replicative senescence (a state of
irreversible cellular growth arrest) and stress-induced premature
senescence (SIPS) from exposure to environmental stresses,
including oxidative stress [3]. Senescent cells adopt an enlarged
morphology and secrete inflammatory factors leading to low-level,
chronic inflammation described as the senescence-associated
secretory phenotype (SASP) [4].
The eye may be a useful site for investigating cellular dynamics
of aging, as the corneal endothelium can be readily visualized
using non-invasive techniques. The corneal endothelium is a
monolayer of mosaic-like cells which lines the inner surface of the
cornea. Human corneal endothelial cells (HCEC) do not have
substantial replicative potential in vivo and their form and quantity
influence the health of the cornea [5]. Cells vary from 4 to 6 mm in
thickness, are up to 20 mm in width, and have a stable,
metabolically efficient hexagonal shape [6]. A key function of
the corneal endothelium is to maintain corneal transparency via
an ionic ‘pump’. Loss of HCEC beyond a critical threshold results
in corneal oedema and loss of visual acuity.
HCEC can be viewed non-invasively via specular microscopy
which uses specular reflection [7]. Three endothelium parameters
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are commonly assessed. Firstly, the number of cells within a
defined area - endothelial cell density (ECD), which decreases [8–
10] throughout life at an average rate of 0.3–0.6%/year [5,11].
Mean cell density is approximately 3400 cells/mm2 at age 15 years
declining to approximately 2300 cells/mm2 by 85 years [12]. The
endothelial response to gradual cell loss is spreading and migration
of neighbouring cells, leading to an increase in overall cell size and
loss of hexagonal shape [5]. Thus, the second parameter that can
be measured is variation in cell size (polymegathism) which is-
measured using the coefficient of variation (CV) of cell area, which
is the ratio between the observed standard deviation and the
arithmetic mean of all the cells examined. An average value is less
than 35. Variation in cell size increases with increasing chrono-
logical age. The final parameter is the hexagonality index – the
proportion of cells with 6 sides and this decreases with increasing
chronological age [13].
Reduction in proliferative capacity of HCEC is partly mediated
by an age-related increase in expression of the cell cycle mediator
CDKN2A [14,15] that functions to hold a cell in a state of growth
arrest. Increasing levels of CDKN2A transcriptional expression
occur with increasing age, in solid organs and peripheral blood
leukocytes [16–19]. Reduction in HCEC proliferative capacity
may also result from nuclear oxidative damage, which can be
assessed by 8-hydroxy-29-deoxyguanosine (8-OHDG) levels, a
physical marker of oxidative DNA damage [3,20]. If premature
cellular senescence occurs in HIV infection, senescent changes in
HCEC may be evident in HIV-infected individuals compared to
age-matched uninfected controls. Nadir CD4 count, current CD4
count and ART duration have frequently been reported as
predictors of increased risk of systemic age-related morbidities in
HIV-infected people [21–24]. We have previously reported from a
South African population that HIV infection is associated with a
functional phenotype consistent with frailty [25], and that changes
in retinal vessel calibre (as a proxy for systemic vasculature) are
consistent with accelerated aging and increased cardiovascular risk
[26]. We now report on the cellular aspects of aging within this
study cohort, using corneal endothelial cells as readily accessible
model of cellular senescence. The objective of this study was to
assess differences and identify predictors of HCEC parameters and
markers of cellular senescence in a cohort of HIV-infected
individuals in comparison to healthy controls.
Methods
Study Participants
HIV-infected participants aged 30 years and above were
enrolled from a community-based HIV treatment centre in
Nyanga district of Cape Town, South Africa [27,28]. Participant
recruitment has been reported in detail elsewhere [25]. In brief, all
participants had a confirmed serological diagnosis of HIV and
were either about to commence ART (ART-naı¨ve), or were
already on first-line ART. A control group of HIV-seronegative
participants was recruited using frequency-matching by gender
and 5-year age categories.
The study was approved by the London School of Hygiene and
Tropical Medicine Ethics Committee and the University of Cape
Town Faculty of Health Sciences Ethics Committee, and adhered
to the tenets of the Declaration of Helsinki. Written informed
consent was obtained from all participants.
Data Collection
Socio-demographic information and medical history were
obtained by questioning participants in their first language (Xhosa
or English). Data were also collected on exposures that are known
to affect aging and age-related parameters (e.g. smoking, work
location as a proxy for UV exposure). Clinical information was
obtained from medical case notes where required. All participants
underwent a full ophthalmic examination including measurement
of visual acuity, evaluation by slit lamp microscopy (for anterior
segment structures e.g. cornea, anterior chamber) and indirect
ophthalmoscopy (for retina and vitreous).
Endothelium Assessment
A non-contact specular microscope was used (SP02, CSO;
Florence, Italy) in automatic release mode to reduce operator-
dependent variables. The operator focused and aligned a real-time
image of the participant’s eye. The instrument captured the
endothelium in the central corneal area, and was calibrated to
account for varying thickness of the central cornea (which has the
potential to affect endothelial cell counts). The instrument software
automatically calculated the quality and reliability of a captured
image; if an image was of poor quality (i.e. not ‘ok’ on the image
quality specification), the measurement was repeated. Participants
who had corneal pathology or evidence of past or current
intraocular inflammation were excluded from analysis. Endothelial
parameter values were extracted from the image captures in a
masked fashion. Two assessments were taken per eye and the
mean was used in analyses. Figure 1 shows an example of the
output.
CDKN2A Expression Determination and 8OHDG
Measurement
RNA was extracted from peripheral blood leukocytes (PBL)
using Trizol reagent (Invitrogen, UK) following manufacturer’s
guidelines. RNA extraction was performed in Cape Town and
samples shipped on dry ice to the University of Glasgow. Relative
quantitative real-time PCR (qRT-PCR) was used to estimate
mRNA levels corresponding to the candidate senescence associ-
ated gene - CDKN2A. Expression levels were measured against a
reference HPRT housekeeping gene on an ABI Prism(R) 7500
Sequence Detection System. Sequences of human TaqManTM
Primer/Probe sets were designed by Primer Express algorithm
(Applied Biosystems, Austin, TX, USA). The comparative
threshold cycle method (DDCT) was employed to quantify relative
gene expression. The quantification result was transformed to an
exponential value, 2–DDCt [29] where Ct is the threshold cycle, or
the cycle when the product was first detected. Prior to this
quantitative study we demonstrated that the efficiency of
amplification of reference (HPRT) and test genes were approxi-
mately equal (data not shown). Plasma 8-OHDG concentration
was quantified using ELISA kits (OxiSelect, Cell Biolabs, CA,
USA) according to manufacturer’s instructions.
Statistical Analyses
One eye per person was randomly selected for analyses. Where
an eye was not available, for example due to trauma, the
contralateral eye was used. Endothelium parameters were assessed
as categorical variables by division into quartiles defined in the
HIV-seronegative participants. The association of HIV status with
these quartiles was assessed in univariable and multivariable
logistic regression models adjusted for risk factors and a priori
confounders (UV exposure, smoking). Linear regression analyses
were also performed to assess the rate of endothelial cell loss per
year in the two groups using age as a continuous variable. The
endothelial parameter phenotypes were further defined with
binary categorization to denote ‘aging’ as follows: low endothelial
cell count (,25th percentile: ,2461cells/mm2), high polymegath-
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ism (.75th percentile: .39), and low hexagonality index (,25th
percentile: ,46). Serum biomarkers (CDKN2A and 8-OHDG)
were analysed as continuous variables and multiple linear
regression models were used to examine the relationships of
biomarker expression with endothelial cell parameters. All
analyses were performed with Stata 11 IC (Stata Corp, USA).
Results
Participant Characteristics
Characteristics of the 242 HIV-infected individuals and 249
uninfected age/gender frequency matched HIV-seronegative
individuals are reported in Table 1. HIV-infected participants
tended to have a greater income (attributable to a government
health-related grant), to be non-smokers, and reported less
consumption of alcohol than HIV-seronegative individuals.
HIV-infected participants were almost twice as likely to have a
history of an eye condition (p = 0.01), but there was little difference
in visual acuity (Table 1). None of the participants had undergone
intraocular surgery in either eye or had evidence of clinically active
uveitis, both of which could have affected the endothelium.
Among the HIV-infected participants, 88% were receiving ART,
the current median CD4 count was 468 cells/mL (interquartile
range: [IQR]: 325–607) and 84% had an undetectable plasma
viral load (VL –defined as ,50 copies/mL).
Corneal Endothelium Assessment
Three participants had corneal pathology precluding accurate
image acquisition (inactive corneal infiltrates of both eyes), leaving
488 eyes for analysis. Endothelium parameter images of sufficient
quality were available for 468 (95.9%) eyes. Acquisition of sub-
optimal images was related to participant movement and rapid
blinking during image capture. Poor quality images were more
frequent in participants with a history of an eye condition
compared to those without (9.4% vs. 3.3%, p = 0.02) and in those
who had HIV infection (5.8% vs. 2.4%, p = 0.06).
Endothelial Cell Density
Median cell density values were 2660 cells/mm2 (IQR: 2433–
2851) in HIV-infected participants and 2614 cells/mm2 (IQR:
2460–2802) in HIV-seronegative individuals (p = 0.56). The age-
adjusted rate of endothelial cell loss was greater in HIV-infected
participants compared to HIV-seronegative individuals (0.30% per
year vs. 0.15%), although this did not reach statistical significance
(p-interaction = 0.16). Table 2 reports the association of the
endothelial cell parameters with HIV status. Table 3 reports
associations of socio-behavioural and clinical factors with low cell
density within the study population. Increasing age was strongly
associated with low cell density, both in univariable and
multivariable analysis (p-trend = 0.001). In addition to increasing
age and male gender, a key finding was that low current CD4
counts were independently associated with low cell density among
HIV-infected individuals (Table 4). Participants with CD4 counts
,200 cells/mL were almost three times more likely to have a low
cell density (OR = 2.77; 95%CI: 1.12–6.81). This association was
strengthened when restricted to participants on ART (n = 198)
(OR = 4.63; 95%CI: 1.48–14.50– data not shown).
Endothelial Cell Polymegathism (Variation in Cell Size)
The median variation in cell size (polymegathism) was 36 (IQR:
33–39) in HIV-infected participants and 35 ([IQR: 32–38],
p = 0.07) in HIV-seronegative individuals. HIV was associated
with higher polymegathism quartiles in univariable analyses (p-
trend = 0.04), and this association strengthened after adjustment
(p-trend = 0.006) (Table 2). HIV infection was also associated with
high polymegathism as a binary variable (OR = 1.67, 95%CI
1.00–2.78) (Table 5). Increasing age, an outdoor work location and
increased duration of smoking were also associated with high
polymegathism. However, despite the association of HIV infection
with this variable, HIV-related covariates were not related.
Independent predictors in HIV-infected individuals were outdoor
work (OR = 2.20; 95%CI: 1.00–4.90) and cigarette smoking
(OR = 3.41; 95%CI: 1.13–10.31) (Table 4).
Hexagonality Index (Cell Shape)
The median hexagonality index was similar in both groups (50
[IQR: 45–54] vs. 50 [IQR: 46–54], p = 0.55). Low hexagonality
index was associated with increasing age (p-trend = 0.006) and
outdoor work location (OR = 1.70; 95%CI 1.04–2.78) but there
was little evidence of an associated with HIV infection (OR = 1.40,
95%CI 0.90–2.17). In HIV-infected individuals, low hexagonality
index was associated with outdoor work (OR = 1.97; 95%CI:
1.00–3.95); and inversely related with a history of an eye condition
(OR = 0.18; 95%CI: 0.07–0.62) (Table 4). No HIV-related
covariates were associated with this endothelial parameter.
Figure 1. Example of corneal endothelial cells captured by specular microscopy. A: Endothelial cells – density is 2454 cells/mm2. B:
Polymegathism assessment – measurement of cell size. C: Pleomorphism assessment – proportion of cells that are hexagonal.
doi:10.1371/journal.pone.0057422.g001
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Association between Markers of Cellular Senescence and
Endothelial Cell Density
CDKN2A measurements were available for 430 participants,
(221 HIV+/209 HIV2). CDKN2A transcriptional expression was
higher in HIV-infected participants compared to HIV-seronega-
tive individuals (0.46 vs. 0.37, p = 0.007). In ART-treated
participants with suppressed viral load (,50 copies/ml; n = 155)
adjusted CDKN2A expression was higher in those with low cell
density compared to those with high cell density (0.57 vs. 0.43,
p = 0.04). There was no evidence to suggest an association
between CDKN2A expression and cell density in HIV-seroneg-
ative individuals (p = 0.33).
8-hydroxy-29-deoxyguanosine (8-OHDG) levels were available
for 70 individuals. 8-OHDG levels were positively associated with
CDKN2A expression in HIV-seronegative individuals, however
the association was non-significant (r = 0.13, p = 0.33). Mean levels
were 0.21ng/ml in HIV-seronegative individuals and 0.22 ng/ml
in HIV-infected individuals (p = 0.83). In participants on ART
with undetectable viral load (n = 28), those with low ECD count
had higher 8-OHDG levels compared to those with high cell
density (0.25 ng/ml vs. 0.19 ng/ml, p = 0.04). There was no
association between 8-OHDG levels and cell density in HIV-
seronegative individuals.
Table 1. Characteristics of study participants.
Variable
HIV-infected participants (242)
% (n)
HIV-seronegative individuals
(249) % (n) P-value
Age (mean6SE) 41.260.5 42.560.6 0.10
Age, years by group
30–39 119 (49.2) 117 (47.0)
40–49 81 (33.5) 79 (31.7) 0.54
.50 42 (17.4) 53 (21.3)
Male gender 25.6 (62) 24.1 (60) 0.70
Working location
Indoors 35.1 (85) 28.1 (70) 0.10
Income
.ZAR1000/month 42.2 (102) 31.7 (79) 0.02
Smoking status
Non-smoker 85.5 (207) 72.7 (181) 0.001
,10 years 4.6 (11) 12.9 (32)
.10 years 9.9 (43) 14.5 (36)
Alcohol
Yes 30.2 (73) 44.2 (110) 0.001
History of eye condition
Yes 16.9 (41) 9.3 (23) 0.01
Visual acuity (presenting) 20/25 20/20 0.68
% with visual acuity ,20/40 6.2 (15) 10.0 (25) 0.12
HIV-related characteristics (n = 242)
WHO stage
1/2 27.3 (66)
3/4 72.7 (176)
ART* naı¨ve 12.0 (29)
CD4 count in ART naı¨ve group (n = 29) 170 (84–201)
Log10VL in ART naı¨ve group (n = 19) 4.81 (4.11–5.14)
Current CD4 count in ART group, ml (n = 213) 468 (325–607)
Nadir CD4 count in ART group, ml 127 (76–171)
% with detectable VL in ART group 16.0 (34)
Peak Log10VL in ART group 4.56 (3.85–4.98)
Duration of ART, months 58 (34–75)
ART Regimen
Containing AZT/3TC 59.6 (127)
Other 40.3 (86)
*ART = Anti-retroviral therapy
doi:10.1371/journal.pone.0057422.t001
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Table 2. Association of endothelial cell parameters with HIV status.
Endothelial cell parameters N (468)
HIV-infected
participants (%) Univariate OR (95%CI) P-value Multivariate1 OR (95%CI) P-value
Endothelial cell density (ECD)
First quartile (lowest) 125 64(28.3) 1 1
Second quartile 98 38 (16.8) 0.60 (0.35–1.03) 0.18 0.62 (0.35–1.10) 0.22
Third quartile 119 58 (25.7) 0.91 (0.55–1.50) 0.93 (0.55–1.57)
Fourth quartile (highest) 126 66 (29.2) 1.05 (0.64–1.72) 1.10 (0.65–1.85)
Polymegathism (variation in cell size)
First quartile 121 51 (22.5) 1 1
Second quartile 129 59 (26.1) 1.16 (0.70–1.91) 0.99 (0.58.1.68)
Third quartile 103 54 (23.9) 1.51 (0.89–2.57) 0.04* 1.52 (0.87–2.67) 0.006*
Fourth quartile 115 62 (27.4) 1.61 (0.96–2.69) 1.99 (1.15–3.45)
Hexagonality index (cell shape)
First quartile 142 74 (32.7) 1 1
Second quartile 117 56 (24.8) 0.84 (0.52–1.36) 0.76 (0.46–1.27)
Third quartile 109 47 (20.8) 0.70 (0.42–1.15) 0.57 0.59 (0.34–1.00) 0.27
Fourth quartile 100 49 (21.7) 0.88 (0.53–1.47) 0.81 (0.48–1.39)
* = p-value: test for trend.
**Adjusted for age, gender, UV exposure, BMI, alcohol and cigarette smoking status, any history of an eye condition.
doi:10.1371/journal.pone.0057422.t002
Table 3. Association of low endothelial cell density in study population (n = 468).
Variable Univariate OR (95%CI) P-value Multivariate1 OR (95%CI) P-value
HIV infection
No 1 1
Yes 1.17 (0.78–1.77) 0.45 1.14 (0.74–1.76) 0.56
Gender
Male 1 1
Female 0.74 (0.47–1.18) 0.20 0.66 (0.39–1.14) 0.14
Age (years)
30–39 1 1
40–49 1.60 (0.99–2.57) 1.60 (0.98–2.61)
.50 2.41 (1.41–4.15) 0.005* 2.43 (1.39–4.24) 0.001*
Work location
Outdoor worker 0.96 (0.62–1.49) 0.87 (0.55–1.37)
Indoor worker 1 0.85 1 0.55
Cigarette smoker
No 1 1
Yes 0.87 (0.52–1.46) 0.60 0.66 (0.34–1.24) 0.20
Alcohol consumption
No 1 1
Yes 0.89 (0.58–1.36) 0.58 0.83 (0.51–1.36) 0.46
History of eye condition
No 1 1
Yes 1.71 (0.96–3.06) 0.07 1.41 (0.77–2.57) 0.27
* = test for trend.
1Adjusted for all other variables in model.
doi:10.1371/journal.pone.0057422.t003
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Discussion
We have already demonstrated in this South African study
population that HIV infection is associated with an increased risk
of frailty, providing evidence that this functional phenotype is
associated with HIV-related accelerated aging [25]. We have also
investigated for evidence of aging at an organ/systems level using
the retinal vessels as a model of the systemic vasculature, and our
findings suggested that HIV infection is associated with changes in
the retinal vasculature that may reflect premature aging and
increased cardiovascular risk [26]. These previous studies both
provided important evidence that HIV infection is associated with
accelerated senescence. The present study further builds on these
findings, using corneal endothelial cells to represent a readily
accessible cellular model of senescence. Here we have demon-
strated that HIV-infected individuals have an increased risk of
greater corneal endothelial cell size variation (polymegathism)
when compared with HIV-seronegative individuals. Furthermore,
HIV-infected individuals with a current CD4 count,200 cells/mL
were more likely to have low endothelial cell densities than those
with higher CD4 counts. These data were corroborated by
markers of cellular damage and senescence which were found to
be higher in virally suppressed ART-treated individuals with low
cell densities. These findings provide further evidence of acceler-
ated aging in HIV, and that this may be influenced by the level of
immunodeficiency, as reflected by CD4 count.
Independent predictors of low cell density in HIV-infected
individuals included age (as anticipated), male gender and low
current CD4 count. The relationship with male gender is likely to
be related to the anti-oxidant and anti-inflammatory properties of
oestrogen [20], while the relationship with low current CD4 count
suggests that poor immune restoration may accelerate senescence.
Our finding that UV exposure and smoking were also independent
predictors of polymegathism in the overall study population and in
HIV-infected individuals supports the findings of others that stress,
including oxidative stress, is likely to be an important contributor
to cellular senescence mechanisms in HCECs [30]. Our observa-
tion of increased CDKN2A levels in PBLs from HIV-infected
individuals compared with HIV-seronegative individuals supports
the mechanism of systemic oxidative stress. Furthermore, exposure
to cigarette smoke has been demonstrated to degrade the function
of the cornea through generation of reactive oxygen species [31].
It is surprising that polymegathism was not associated with current
CD4 count or other HIV-related covariates in our study. This may
suggest that ‘stress’ induced by HIV-related chronic inflammation
may lead to HCEC senescence, the initial features of which are an
Table 4. Multivariable models to demonstrate association of endothelial cell parameters in HIV-infected individuals (n = 217).
Variable Low endothelial cell density
1
High polymegathism1 (cell
variation)
Low hexagonality index1 (cell shape
not 6-sided)
OR P-value OR P-value
Gender
Male 1 1 1
Female 0.43 (0.19–0.91) 0.04 2.19 (0.81–5.86) 0.12 0.99 (0.44–2.29) 0.98
Age (years)
30–39 1 1 1
40–49 2.84 (1.35–5.97) 1.00 (0.43–2.31) 0.63 (0.30–1.34)
.50 5.42 (2.21–13.26) ,0.0001* 2.44 (0.97–6.13) 0.09* 1.69 (0.71–3.98) 0.12
Work location
Outdoor worker 0.57 (0.29–1.12) 2.20 (1.00–4.90) 1.97 (1.00–3.95)
Indoor worker 1 0.11 1 0.05 1 0.05
Cigarette smoker
No 1 1 1
Yes 1.04 (0.39–2.78) 0.93 3.41 (1.13–10.31) 0.03 1.09 (0.39–3.06) 0.87
History of eye condition
No 1 1 1
Yes 1.04 (0.44–2.49) 0.93 0.95 (0.37–2.49) 0.93 0.18 (0.05–0.62) 0.01
WHO clinical stage
1/2 1 1 1
3/4 1.58 (0.71–3.51) 0.26 1.88 (0.80–4.54) 0.16 1.11 (0.52–2.33) 0.79
Peak viral load
,10,000 copies 1 1 1
.10,000 copies 0.65 (0.32–1.31) 0.23 0.87 (0.40–1.86) 0.71 0.84 (0.42–1.69) 0.62
Current CD4 count
,200 cells/ml 2.77 (1.12–6.81) 1.30 (0.49–3.48) 0.62 (0.24–1.61)
.200 cells/ml 1 0.03 1 0.60 1 0.33
1Adjusted for all other variables in model.
* = test for trend.
doi:10.1371/journal.pone.0057422.t004
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enlarged (or variation in) morphology. Severe immunodeficiency
(manifest as a low CD4 count) may be associated with later
features of the senescence pathway, ultimately leading to cell cycle
arrest and cell loss.
Despite the association of greater polymegathism (variation in
cell size) with HIV, we did not detect a difference in cell density
between the two groups. The endothelial response to gradual cell
loss is spreading and migration of neighbouring cells with an
increase in overall cell size and adoption of a non-hexagonal shape
[5]. Therefore an overall decrease in ECD might be have been
expected. However, as increased polymegathism reflects a variation
in cell size (not simply an increase in cell size), similar ECD
between the two groups is not an unusual finding: ECD can
remain the same with different levels of polymegathism. Other
studies have reported similar findings [32] and patients with
diabetes develop increased polymegathism while retaining normal
endothelial cell density for their age [33]. Stress to the
endothelium can also lead to cell border changes, with cells
expressing a large anterior surface area with a small posterior
surface area or vice versa [34]. Capturing a two-dimensional
image with the specular microscope may, therefore, provide
unchanged cell density measures despite greater polymegathis-
m.An aggregate of phenotypes has been described for senescent
cells [4,35], including irreversible growth arrest, an enlarged
morphology, expression of CDKN2A and the senescence-associ-
ated secretory phenotype (SASP). This cell phenotype is associated
with secretion of cytokines, growth factors and proteases that can
lead to low-level chronic inflammation that is a feature of normal
aging, and also a key feature in HIV infection [36]. In our study,
higher CDKN2A expression in peripheral blood leukocytes and 8-
OHDG levels plasma were observed in participants on ART with
undetectable viral load and low endothelial cell density, suggesting
that accelerated cellular senescence may be occurring systemically.
Markers of cellular senescence have also been detected within
endothelial corneal tissue, from human subjects and mouse
senescence models, showing greater CDKN2A expression with
increasing age [37,38]. In addition, HCECs exhibit signs of
oxidative DNA damage, and significantly higher levels of 8-
OHDG have been reported in corneas from older donors
compared with younger donors [3]. Our findings suggest that
corneal endothelial cells in HIV-infected individuals exhibit some
of the phenotypic features of senescent cells. Consequently, they
would be expected to express more CDKN2A and have the
associated SASP compared to HIV-seronegative individuals. This
phenotype may also provide a possible mechanism to account for
the substantial excess risk of conjunctival malignancies (particu-
larly squamous cell carcinomas [SCC]) seen among HIV-infected
individuals [39]. An underlying infectious aetiology for these
malignancies has been investigated, but none found to date [40]. It
is possible that SASP-associated chronic inflammation could lead
Table 5. Association of high polymegathism (increased variation of cell size) in study population (n = 468).
Variable Univariate OR (95%CI) P-value Multivariate1 OR (95%CI) P-value
HIV infection
No 1 1
Yes 1.26 (0.78–2.01) 0.34 1.67 (1.00–2.78) 0.04
Gender
Male 1 1
Female 1.54 (0.86–2.78) 0.15 2.79 (1.35–5.77) 0.006
Age (years)
30–39 1 1
40–49 1.43 (0.83–2.48) 1.31 (0.74–2.33)
.50 2.33 (1.28–4.25) 0.02 2.33 (1.23–4.40) 0.01*
Work location
Outdoor worker 1.78 (1.02–3.10) 1.76 (.100–3.12)
Indoor worker 1 0.04 1 0.05
Cigarette smoker
Nil 1 1
5 yrs or less 1.91 (0.72–5.07) 2.07 (0.71–6.02)
6–15 1.27 (0.46–3.16) 2.34 (0.73–7.44)
16–20 1.69 (0.65–4.44) 2.47 (0.83–7.39)
.20 1.87 (0.75–4.64) 0.43 2.72 (0.91–8.12) 0.02*
Alcohol consumption
No 1 1
Yes 0.77 (0.47–1.22) 0.26 0.70 (0.39–1.24) 0.22
History of eye condition
No 1 1
Yes 1.71 (0.96–3.06) 0.07 0.80 (0.38–1.72) 0.57
* = test for trend.
1Adjusted for all other variables in model.
doi:10.1371/journal.pone.0057422.t005
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to metaplastic and/or neoplastic change within conjunctiva as well
as contributing to accelerated cellular senescence. Measurement of
CDKN2A expression in conjunctival SCC specimens from HIV-
infected individuals would be the ideal next step to investigate this
hypothesis.
A key strength of our study is the inclusion of an age- and
gender-matched control group with a similar socio-demographic
profile to the HIV-infected participants. The hypothesis of
accelerated aging in HIV has received criticism due to limitations
in characterization of participants, in particular the possibility of
differential exposure to potential risk factors between HIV-infected
and uninfected populations [24,41,42]. By recruiting from the
same community, we reduced the likelihood of differential risk
exposure. HCEC change morphology and assume an ‘aged
phenotype’ in several chronic systemic diseases (e.g. renal failure
and diabetes) [43] [44,45], suggesting that they may be useful in
assessing cellular senescence, particularly as measurement is
objective and non-invasive.
There are some limitations to our study. Although our
hypothesis relates to accelerated aging in HIV, it is possible that
subclinical intraocular inflammation could account for the
observed relationship between lower CD4 counts and low
endothelial cell density. HIV can replicate within the eye causing
uveitis [46], and a low CD4 count is a risk factor for immune
recovery uveitis (IRU) [47] which could arise in patients with a
history of cytomegalovirus (CMV) infection and could potentially
cause subclinical endothelial damage. However, we did not detect
any evidence of IRU, and we have previously shown the
prevalence of CMV retinitis to be very low within this population
[48]. Therefore, our data support the hypothesis of premature
aging in line with systemic co-morbidities [21,49]. Another
limitation is that misclassification of smoking and alcohol
consumption status may have occurred, with HIV-infected
participants wanting to demonstrate ‘healthy behaviour’, which
could have led to confounding. Our measure of location of work as
a proxy measure of ultra-violet exposure may also have been
confounded by socio-economic status. Finally, CDKN2A expres-
sion and 8-OHDG levels were determined in peripheral blood
leukocytes and plasma, which may not directly reflect levels in
corneal tissue therefore some caution should be excised when
interpreting these differences. However, a number of studies
indicate that CDKN2A transcriptional expression increases with
increasing chronological age in both leukocytes and solid organs
[16,17,19]. A direct comparison of CDKN2A and 8-OHDG levels
we believe is novel in this context. The positive correlation
(although not significant) is intuitive, with more DNA damage
reflected in more senescent cells, as determined by CDKN2A
expression levels. Our study may simply be limited by lack of
power in the 8-OHDG samples measured.
In summary, corneal endothelial cells demonstrate features of
senescence in HIV-infected individuals, suggesting HIV infection
contributes towards accelerated cellular senescence. Evaluation of
corneal endothelial cells in longitudinal studies of HIV-related
accelerated biological aging may reveal further insights into the
mechanisms of cellular senescence in this population.
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